key: cord-0747018-5kt1sky8
authors: Núñez, Isaac; Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.
title: Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases – an analysis of Mexico’s capital
date: 2022-02-11
journal: Public Health
DOI: 10.1016/j.puhe.2022.02.010
sha: 2c7ebdd79294adcebbaed72c2debdafd5e605d08
doc_id: 747018
cord_uid: 5kt1sky8

Objectives Case definitions are vital in a pandemic to effectively identify, isolate, and contact trace, particularly were testing is slow, scant, or not available. While case definitions have been developed in the COVID-19 pandemic, their diagnostic properties have not been adequately assessed. This study’s objective is to determine the diagnostic properties of local and World Health Organization (WHO) COVID-19 case definitions in the large metropolitan area of Mexico City. Methods We calculated the diagnostic properties of five COVID-19 definitions (three of the Mexican government and two of the WHO) using open data of suspected COVID-19 cases in Mexico City from March 24th 2020 until May 15th 2021. Results All 2 564 782 people included in the analysis met the WHO suspected case definition (sensitivity 100%, specificity 0%). The WHO probable case definition was met by 1.2%, while the first and second Mexican suspected case had sensitivities of 61% and specificities of 61 and 67%, respectively. Confirmed case by epidemiological contact had a low sensitivity (32%) but slightly higher specificity (81%). Conclusions Case definitions should maximize sensitivity, especially in a high-transmission area such as Mexico City. The WHO suspected case definition has the potential for detecting most symptomatic cases. We underline the need for routine evaluation of case definitions as new evidence arises to maximize their usefulness.

Epidemiologic case definitions for a disease are vital in surveillance during epidemics. In 24 this context, the aim of a case definition is to be highly sensitive as to miss the fewest true 25 cases of the disease. In low-income countries, case definitions are valuable to make 26 decisions on isolation, contact tracing, and monitoring disease trends, since definitive tests 27 might be scarce, unavailable, and highly expensive. 1 During the COVID-19 pandemic the 28 World Health Organization (WHO) released case definitions for suspected, probable and 29 definitive COVID-19 cases, which have been periodically updated. 2 Countries also released 30 definitions with irregular updating, even though they should be revised according to new 31 scientific evidence as to increase their diagnostic value. 1-4 32 Mexico released the first version of its COVID-19 suspected case definition in March 2020 33 with the aim of determining who should be tested. Only one in ten ambulatory suspected 34 COVID-19 patients would be tested, as well as all hospitalized ones. An update in the case 35 definition was published in august 2020 with minor changes, but the testing strategy 36 remained the same. [3] [4] Considering this deliberate under-testing, suspected case definitions 37 become especially important to account for disease undercounting, initiate contact tracing 38 (which has not been a feature of Mexico's pandemic response, but is elsewhere), and 39 starting individual treatment. An important caveat is that the people who design these 40 definitions are in many cases not the same people that have to apply them on the field. 41

Thus, a dissociation could occur between intended and actual use. 42

Mexico City is a large metropolitan area with 9 209 944 habitants. 5 In this analysis we 43 calculated the diagnostic properties of the definitions of COVID-19 cases of Mexico's 44

Ministry of Health (from now on, simply Mexico) and those of the WHO, to determine 45 their adequacy for epidemiological monitoring purposes. 46

We used open data from the Mexico City government for reported cases of suspected 48 COVID-19 between March 24th 2020 and May 15th 2021. 6 We calculated the diagnostic 49 properties (sensitivity, specificity, positive predictive value, negative predictive value, 50 positive likelihood ratio, and negative likelihood ratio), as well as post-test probabilities of 51 five different epidemiological COVID-19 case definitions: three issued by Mexico for 52 COVID-19 surveillance purposes (suspected case, updated suspected case definition, and 53 suspected case "confirmed" by epidemiological linkage to a laboratory confirmed case) and 54 two WHO recommended definitions (suspected and probable). 2-4 55 A comparison between these definitions is provided in Table 1 . Mexico's COVID-19 56 suspected case definition was issued in March 2020 and included anybody seeking care for 57 at least one of the following symptoms starting within the 7 previous days: cough, dyspnea, 58 fever or headache; with at least one of the following: myalgia, arthralgia, sore throat, 59 thoracic pain, rhinorrhea, polypnea or conjunctivitis. 3 COVID-19 suspected case definition 60 was updated by Mexico in August 2020 (adding chills, anosmia and dysgeusia and 61 expanding the period of symptoms onset from 7 to 10 days). 4 The case definition for 62 COVID-19 confirmed by epidemiological linkage to a laboratory confirmed case (anyone 63 meeting the COVID-19 suspected case criteria that have had contact with a laboratory 64 confirmed case within the previous 14 days). 4 We substituted contact with "confirmed 65 case" with contact with an "individual with respiratory symptoms", as only information on 66 this variable was available. Table 1 ) and probable cases (which requires the 74 presence of the clinical criteria in suspected cases (acute onset of fever and cough OR acute 75 onset of any three or more of the following symptoms: fever, cough, general 76 weakness/fatigue, headache, myalgia, sore throat, coryza, dyspnea, 77 anorexia/nausea/vomiting, diarrhea, altered mental status in combination) in combination 78 with chest imaging showing findings suggestive of COVID-19 disease, which we replaced 79 with the variable "clinical diagnosis of pneumonia", since no data on chest-imaging was 80

Since all tested patients in Mexico are symptomatic, the diagnostic gold standard for our 82 calculation of the diagnostic properties of case definitions was having either a positive real-83 time reverse-transcriptase polymerase chain reaction (RT-PCR) or a positive antigen test. 84

Post-test probabilities of COVID-19 were calculated using the daily proportion of positive 85 molecular or antigen tests and graphed using 7-day rolling means. 86

All analyses were performed with R version 4.0.0. This study did not require ethics board 87 approval because it used publicly available anonymized data, with no interaction between 88 A suspected case definition that is not met by many confirmed cases is not useful, for 120 epidemiologic purposes or otherwise. Our analysis underlines the importance of this, as 121

Mexico is a country that tests a small percentage of symptomatic people. In our context, 122

suspected cases based on symptoms should include all but asymptomatic individuals as the 123 WHO suspected case definition does, and be formally counted and included in 124 epidemiologic surveillance, as most do not have access to confirmatory tests. 125

Thus, the high sensitivity of the WHO suspected case definition could potentially reduce 126 case sub-estimation and should be preferred when guiding testing decisions in Mexico City 127 and elsewhere. We consider results would be similar if we replicated the analysis country 128 wide, unfortunately we do not have the data to do so. 129

As only symptomatic people are being tested, clinical judgement remains key and patients 130 should be retested in case of a negative result if prevalence remains high. 8 Point-of-care 131 tests might be very useful in these contexts, as their low cost allows for repeated testing. 8 132

Our study has several limitations. We did not have information on several variables, such as 134 anosmia, dysgeusia, and radiological imaging. The incidence of anosmia and/or dysgeusia 135 in Mexican COVID-19 patients is unknown, but elsewhere it has been reported in 35%. 9 136 This could improve the sensitivity of Mexico's second definition. Only one in ten 137 ambulatory patients are tested, and these patients could differ in ways that we are unable to 138 account for, such as subjective disease severity. Furthermore, false negative tests are well 139 known and limit our definition of gold standard. 10-12 This is especially important given the 140 high post-test probability observed throughout the study period (>10% We thank health workers from Mexico for their invaluable work during the pandemic, even 157 under the harshest of conditions. 158

Funding: none. 

Probable case of SARS-CoV-2 infection Any person that presented in the last seven days any one of these symptoms: cough, dyspnea, fever or headache AND at least one of the following: -Myalgias -Arthralgias -Sore throat -Chest pain -Rinorrhea -Polypnea -Conjunctivitis Any person that presented in the last ten days any one of these symptoms: cough, dyspnea, fever or headache AND at least one of the following: -Myalgias -Arthralgias -Sore throat -Chills -Chest pain -Rinorrhea -Polypnea -Conjunctivitis -Anosmia -Dysgeusia Any person that presented in the last ten days any one of these symptoms: cough, dyspnea, fever or headache AND at least one of the following: -Myalgias -Arthralgias -Sore throat -Chills -Chest pain -Rinorrhea -Polypnea -Conjunctivitis -Anosmia -Dysgeusia

Contact with a laboratory confirmed COVID-19 case during the last 14 days.

One of three options must be met, A through C:

A person who meets the clinical AND epidemiological criteria: 

Systematic Review and Meta-analysis of 188

Smell and Taste Disorders in COVID-19

Variation in False-Negative rate of 190

Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time 191

Since Exposure

Assessing case definitions in the absence of a 193 diagnostic gold standard

Negative Results for SARS-CoV-2 Surveillance in Mexico